Upcoming Courses

27th Annual Summer Seminars: Psychopharmacology: A Master Class

Nassir Ghaemi, MD, MPH

August 1, 2016 – August 5, 2016 | North Falmouth, MA | Sea Crest Beach Hotel More Information

This seminar is intended to challenge clinicians to advance beyond standard psychopharmacology to a more advanced level of deciding when and how to use medications in the treatment of psychiatric conditions. Conceptual models about psychopharmacology will be explored, and symptom-oriented versus disease-oriented treatment approaches will be contrasted. Accordingly, symptomatic versus disease-modifying uses of drugs will be examined. The course will emphasize the importance of diagnostic validity for the disease-oriented approach to treatment. Hence, critical analysis will be provided of important DSM-5 diagnostic constructs, such as major depressive disorder, adult ADHD, anxiety disorders, and borderline personality. The utility of agents for those conditions will be examined in the context of examining diagnostic validity. The risk-benefit calculation in medication decision-making will be explored in detail based on the above considerations, as well as detailed examination of scientific evidence regarding frequency and severity of side effects with various agents. In addition to the above diagnoses, attention will be given to schizophrenia and bipolar illness, with detailed discussion of the concept of manic-depressive illness, its diagnostic subtypes, and its treatment with varied drug classes. Special attention will be given to mixed states and to bipolar depression. The major recent NIMH multicenter drug studies – CATIE, STEP-BD, and STARD – will be examined in detail. Recent studies will be emphasized, and meta-analyses provided frequently. Drug classes to be examined in detail are antidepressants, antipsychotics, mood stabilizers, anti anxiety agents, and amphetamines. Special discussion will be provided about use of medications and diagnostic validity of common diagnoses in children and in the elderly. Specific attention will be given to whether and which medications prevent or can worsen risk of suicide. Educational presentation will be in seminar format and include lectures, participant discussions and Q&A. This seminar is designed for the experienced clinician. Course participants will be expected to have had clinical experience, familiarity with the neurobiological contributions to psychiatric illnesses as well as an understanding of the basic therapeutic mechanisms of psychotropic medications.

This course is designed so that participants will be able to:
  • Evaluate the evidence for the diagnostic validity of key DSM-5 constructs;
  • Discuss different diagnostic definitions of mood illness, including DSM and non-DSM-5 approaches;
  • Implement clinical practice with antipsychotics based on the best randomized clinical trials for schizophrenia, bipolar disorder
    and depression;
  • Implement clinical practice with mood stabilizers based on the best randomized clinical trials for bipolar disorder and depression;
  • Implement clinical practice with antidepressants based on the best randomized clinical trials for depression and bipolar disorder;
  • Describe the mechanisms, risks, and benefits of amphetamines for ADHD in children and adults;
  • Describe the risks and benefits of antipsychotics, antidepressants, mood stabilizers and anti anxiety agents.

Additional Information

Monday, August 1, 2016

8:30-9:00 AM

Registration

9:00-10:15 AM

Basic neurobiology and pharmacodynamics and pharmacokinetics.

10:15-10:30 AM

Continental Coffee Break

10:30-12:15 PM

Anxiety disorders and insomnia; pharmacology of the major psychotropic drug classes; Q&A; group discussions.

Tuesday, August 2, 2016

9:00-10:15 AM

Statistics principles for study interpretation; antipsychotics: clinical psychopharmacology trials in schizophrenia, bipolar disorder, and depression: evaluation of efficacy and safety data.

10:15-10:30 AM

Continental Coffee Break

10:30 AM-12:15 PM

Side effects and risk; Q&A discussion.

Wednesday, August 3, 2016

9:00-10:15 AM

Mood stabilizers: nosology of bipolar disorders; research evidence for mood stabilizer use in mood disorders.

10:15-10:30 AM

Continental Coffee Break

10:30 AM-12:15 PM

Side effects and risk; clinical practice with mood stabilizers; Q&A.

Thursday, August 4, 2016

9:00-10:15 AM

Depression: antidepressants and amphetamines; tricyclics, SSRIs and new antidepressants.

10:15-10:30 AM

Continental Coffee Break

10:30 AM-12:15 PM

Combination and augmentation strategies; research evidence for anti-depressant use amphetamines use and side effects and risk.

Friday, August 5, 2016

9:00-10:15 AM

Amphetamines and ADHD; personality disorders; special topics.

10:15-10:30 AM

Continental Coffee Break

10:30 AM-12:15 PM

Q&A and discussion.

12:15 PM

Adjourn

Beth Israel Deaconess Department of Psychiatry Foundation, Inc./Contact Hours: 15

Accreditation:

Physicians This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of pmiCME and The Continuing Education Program at Beth Israel Deaconess Medical Center. pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION:

Weeklong Seminar: pmiCME designates the live activity for a maximum of 15 AMA PRA Category 1 Credits™
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits(ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©), therefore up to 15 ECMEC© Credits are available. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Psychologists The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School is approved by the American Psychological Association to offer continuing education for psychologists. The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School maintains responsibility for this program and its content.

Counselors The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 5689. Programs that do not qualify for NBCC credit are clearly identified. The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School is solely responsible for all aspects of the programs.

Social Workers For information on the status of the application to the Massachusetts Chapter of the National Association of Social Workers, please call 617-754-1265 or email: sjruiz@bidmc.harvard.edu.

Nurses Applications have been made for the following programs to the Massachusetts Association of Registered Nurses Inc. an approved provider of nursing credits by the American Nurses Credentialing Center’s Commission on Accreditation.

Nassir Ghaemi, MD, MPH is Professor of Psychiatry, Tufts University School of Medicine and Lecturer on Psychiatry, Harvard Medical School. Dr. Ghaemi is also the recipient of a Master of Arts Degree in Philosophy and a Master of Public Health in the Clinical Effectiveness Program of Harvard School of Public Health. He is Director, Mood Disorders Program, Tufts Medical Center. Dr. Ghaemi has authored over 100 scientific articles or book chapters and serves on the editorial boards of numerous journals. He is the author of 4 books including, Mood Disorders: A Practical Guide.His most recent book (a New York Times Best Seller) is, A First Rate Madness: Uncovering the Links between Leadership and Mental Illness.